To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Update on research and tr… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Update on research and treatment of premenstrual dysphoric disorder.

Journal article
Authors Joanne Cunningham
Kimberly Ann Yonkers
Shaughn O'Brien
Elias Eriksson
Published in Harvard review of psychiatry
Volume 17
Issue 2
Pages 120-37
ISSN 1465-7309
Publication year 2009
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 120-37
Language en
Links dx.doi.org/10.1080/1067322090289183...
Keywords Female, Humans, Premenstrual Syndrome, drug therapy, epidemiology, psychology, Quality of Life, psychology, Severity of Illness Index, Social Behavior, Somatoform Disorders, diagnosis, epidemiology, psychology
Subject categories Pharmacology and Toxicology

Abstract

Many women in their reproductive years experience some mood, behavioral. or physical symptoms in the week prior to menses. Variability exists in the level of symptom burden in that some women experience mild symptoms, whereas a small minority experience severe and debilitating symptoms. For an estimated 5%-8% of premenopausal women, work or social functioning are affected by severe premenstrual syndrome. Many women in this group meet diagnostic criteria for premenstrual dysphoric disorder (PMDD). Among women who suffer from PMDD, mood and behavioral symptoms such as irritability, depressed mood, tension, and labile mood dominate. Somatic complaints, including breast tenderness and bloating, also can prove disruptive to women's overall functioning and quality of life. Recent evidence suggests that individual sensitivity to cyclical variations in levels of gonadal hormones may predispose certain women to experience these mood, behavioral, and somatic symptoms. Treatments include: antidepressants of the serotonin reuptake inhibitor class, taken intermittently or throughout the menstrual cycle; medications that suppress ovarian cyclicity; and newer oral contraceptives with novel progestins.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?